The dosimetric impact of the prescription isodose line (IDL) on the quality of robotic stereotactic radiosurgery (SRS) plans.

Abstract

There is no consensus on the optimal prescription isodose line (IDL) in CyberKnife (CK) SRS. We designed a strategy to search for optimal CK plans at different levels of IDLs and investigated the dosimetric impact on the quality of CK plans. The retrospective study consisted of 13 CK patients with 16 brain tumors. The mean volume and size of the tumors was 9.7±10.4cc and 30.3±10.9mm, respectively. Four shells were created at distances of 2-3mm to 60mm from the target. The constraint dose of the innermost shell (D1) was the primary optimization parameter. For isolated brain tumors, D1 started from the prescription dose and gradually reduced after optimization started over. The optimal plans were reached when the coverage started to degrade and the desired IDL was achieved. For eight tumors abutting an OAR, both the D1 and constraint dose to the OAR were gradually pushed until an optimal plan was reached for the desired IDL. For the isolated tumors, the V5Gy, V10Gy, V15Gy, V20Gy, and V25Gy of low IDL (49.6±2.1%) plans were on average 23.6%, 28.6%, 33.8%, 26.2%, and 10.6% lower, respectively, comparing to the high IDL (88.6±1.3%) plans. The Conformality Index (CI) of the low IDL plans outperformed the high IDL plans (mean: 1.15 vs. 1.24), except for a lesion under 0.5cc. The quality of the middle IDL plans (69.6±1.5%) was close to the low IDL plans. Similar results were observed for tumors abutting an OAR. Low IDL plans outperformed high IDL plans for all metrics in tumors>0.5cc. The lower dose exposure of normal brain tissue and better CI could potentially reduce radiation necrosis while the higher maximum dose could improve local control.